Guardian Pharmacy Services, Inc.

GRDN Healthcare Medical Care Facilities

Guardian Pharmacy Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.9% from fiscal 2024. In the quarter to June 2026, revenue grew 2.16%, EPS grew 133.3% and free cash flow grew 60.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

39.41 0.27 −0.68%
Market cap
$2.5B
P/E
37.5×
Fwd P/E
39.5×
Dividend yield
—
F-score
7/9
Altman Z
10.28
Beneish M
−2.95
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
39.88 44.31 38.09 40.35

+8 more quarters

P/S ratio
1.81 1.64 1.30 1.17
P/FCF ratio
33.23 33.93 23.26 23.90
P/Operating CF
88.31 393.38 54.25 57.85
P/B ratio
10.29 10.26 8.61 8.34
EV/Sales
1.78 1.62 1.28 1.17
EV/EBITDA
23.90 23.49 19.47 20.28
EV/FCF
32.59 33.56 22.92 23.93
Current Ratio
1.65 1.46 1.38 1.22
Net Debt/EBITDA
(3.40) (2.74) (1.80) (1.64)
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
2.51% 2.26% 2.63% 2.48%
Free Cash Flow Yield
3.01% 2.95% 4.30% 4.18%
Free Cash Flow per Share
0.40 0.02 0.49 0.37
Book value per Share
4.07 3.67 3.49 3.15
Free Cash Flow
25.14 1.31 30.37 22.96
EV/EBIT
30.44 30.48 25.45 27.80
Other line items

Show all line items

Columns are period end dates